A citation-based method for searching scientific literature

Francisco Zafra, Ignacio Ibáñez, Cecilio Giménez. Neuronal Signal 2016
Times Cited: 8







List of co-cited articles
72 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain.
Yoshihiro Takahashi, Koji Hara, Yasunori Haranishi, Tadanori Terada, Goh Obara, Takeyoshi Sata. Pharmacol Biochem Behav 2015
10
50

Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
Katsuya Morita, Naoyo Motoyama, Tomoya Kitayama, Norimitsu Morioka, Koki Kifune, Toshihiro Dohi. J Pharmacol Exp Ther 2008
96
37

Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain.
A Mingorance-Le Meur, P Ghisdal, B Mullier, P De Ron, P Downey, C Van Der Perren, V Declercq, S Cornelis, M Famelart, J Van Asperen,[...]. Br J Pharmacol 2013
36
37

Glycine transport inhibitors for the treatment of pain.
Robert J Vandenberg, Renae M Ryan, Jane E Carland, Wendy L Imlach, Macdonald J Christie. Trends Pharmacol Sci 2014
49
37



Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain.
Beatriz Cubelos, Cecilio Giménez, Francisco Zafra. Cereb Cortex 2005
221
37

Analgesic effect of GT-0198, a structurally novel glycine transporter 2 inhibitor, in a mouse model of neuropathic pain.
Yu Omori, Mayumi Nakajima, Kazumi Nishimura, Eiki Takahashi, Tadamasa Arai, Masato Akahira, Tomohiko Suzuki, Mie Kainoh. J Pharmacol Sci 2015
11
37

Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
Toshihiro Dohi, Katsuya Morita, Tomoya Kitayama, Naoyo Motoyama, Norimitsu Morioka. Pharmacol Ther 2009
77
37

Relief of cancer pain by glycine transporter inhibitors.
Naoyo Motoyama, Katsuya Morita, Seiji Shiraishi, Tomoya Kitayama, Takashi Kanematsu, Yasuhito Uezono, Toshihiro Dohi. Anesth Analg 2014
13
37

Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality.
Jesús Gomeza, Koji Ohno, Swen Hülsmann, Wencke Armsen, Volker Eulenburg, Diethelm W Richter, Bodo Laube, Heinrich Betz. Neuron 2003
230
37

Long-term application of glycine transporter inhibitors acts antineuropathic and modulates spinal N-methyl-D-aspartate receptor subunit NR-1 expression in rats.
Franziska Barthel, Andrea Urban, Lukas Schlösser, Volker Eulenburg, Robert Werdehausen, Timo Brandenburger, Carmen Aragon, Inge Bauer, Henning Hermanns. Anesthesiology 2014
25
37

Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.
Eloisa Carta, Seo-Kyung Chung, Victoria M James, Angela Robinson, Jennifer L Gill, Nathalie Remy, Jean-François Vanbellinghen, Cheney J G Drew, Sophie Cagdas, Duncan Cameron,[...]. J Biol Chem 2012
57
37

Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.
Mark I Rees, Kirsten Harvey, Brian R Pearce, Seo-Kyung Chung, Ian C Duguid, Philip Thomas, Sarah Beatty, Gail E Graham, Linlea Armstrong, Rita Shiang,[...]. Nat Genet 2006
158
37

The genetics of hyperekplexia: more than startle!
Robert J Harvey, Maya Topf, Kirsten Harvey, Mark I Rees. Trends Genet 2008
142
37

E3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2.
A de la Rocha-Muñoz, E Núñez, E Arribas-González, B López-Corcuera, C Aragón, J de Juan-Sanz. Sci Rep 2019
5
60

The beta subunit determines the ligand binding properties of synaptic glycine receptors.
Joanna Grudzinska, Rudolf Schemm, Svenja Haeger, Annette Nicke, Guenther Schmalzing, Heinrich Betz, Bodo Laube. Neuron 2005
279
25

2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors.
Koc-Kan Ho, Kenneth C Appell, John J Baldwin, Adolph C Bohnstedt, Guizhen Dong, Tao Guo, Robert Horlick, Khondaker R Islam, Steven G Kultgen, Christopher M Masterson,[...]. Bioorg Med Chem Lett 2004
14
25

The glycinergic system in human startle disease: a genetic screening approach.
Jeff S Davies, Seo-Kyung Chung, Rhys H Thomas, Angela Robinson, Carrie L Hammond, Jonathan G L Mullins, Eloisa Carta, Brian R Pearce, Kirsten Harvey, Robert J Harvey,[...]. Front Mol Neurosci 2010
43
25

A feed-forward spinal cord glycinergic neural circuit gates mechanical allodynia.
Yan Lu, Hailong Dong, Yandong Gao, Yuanyuan Gong, Yingna Ren, Nan Gu, Shudi Zhou, Nan Xia, Yan-Yan Sun, Ru-Rong Ji,[...]. J Clin Invest 2013
152
25

The glycinergic control of spinal pain processing.
H U Zeilhofer. Cell Mol Life Sci 2005
142
25


Lipid inhibitors of high affinity glycine transporters: identification of a novel class of analgesics.
Jane E Carland, Cheryl A Handford, Renae M Ryan, Robert J Vandenberg. Neurochem Int 2014
12
25


Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion--Possible implications for neuropathic pain.
Lukas Schlösser, Franziska Barthel, Timo Brandenburger, Elena Neumann, Inge Bauer, Volker Eulenburg, Robert Werdehausen, Henning Hermanns. Neurosci Lett 2015
11
25

Dorsal Horn Parvalbumin Neurons Are Gate-Keepers of Touch-Evoked Pain after Nerve Injury.
Hugues Petitjean, Sophie Anne Pawlowski, Steven Li Fraine, Behrang Sharif, Doulia Hamad, Tarheen Fatima, Jim Berg, Claire M Brown, Lily-Yeh Jan, Alfredo Ribeiro-da-Silva,[...]. Cell Rep 2015
144
25

Novel glycine transporter type-2 reuptake inhibitors. Part 1: alpha-amino acid derivatives.
Ronald L Wolin, Hariharan Venkatesan, Liu Tang, Alejandro Santillán, Tristin Barclay, Sandy Wilson, Doo Hyun Lee, Timothy W Lovenberg. Bioorg Med Chem 2004
8
25

The first potent and selective inhibitors of the glycine transporter type 2.
W L Caulfield, I T Collie, R S Dickins, O Epemolu, R McGuire, D R Hill, G McVey, J R Morphy, Z Rankovic, H Sundaram. J Med Chem 2001
73
25



A series of case studies: practical methodology for identifying antinociceptive multi-target drugs.
Min-Hee Pang, Yuntae Kim, Kyung Woon Jung, Sunyoung Cho, Doo H Lee. Drug Discov Today 2012
34
25

Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain.
Henning Hermanns, Uta Muth-Selbach, Ruth Williams, Sabrina Krug, Peter Lipfert, Robert Werdehausen, Sebastian Braun, Inge Bauer. Neurosci Lett 2008
42
25

Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition.
Jesús Gomeza, Swen Hülsmann, Koji Ohno, Volker Eulenburg, Katalin Szöke, Diethelm Richter, Heinrich Betz. Neuron 2003
235
25

Actions of N-arachidonyl-glycine in a rat inflammatory pain model.
Rebecca Succar, Vanessa A Mitchell, Christopher W Vaughan. Mol Pain 2007
50
25

Novel glycine transporter type-2 reuptake inhibitors. Part 2: beta- and gamma-amino acid derivatives.
Ronald L Wolin, Alejandro Santillán, Tristin Barclay, Liu Tang, Hariharan Venkatesan, Sandy Wilson, Doo Hyun Lee, Timothy W Lovenberg. Bioorg Med Chem 2004
14
25

The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain.
Robert Werdehausen, Sebastian Mittnacht, Lucy A Bee, Michael S Minett, Anja Armbruster, Inge Bauer, John N Wood, Henning Hermanns, Volker Eulenburg. Pain 2015
25
25



Glycine transporter2 inhibitors: Getting the balance right.
Robert J Vandenberg, Shannon N Mostyn, Jane E Carland, Renae M Ryan. Neurochem Int 2016
15
25

Glycine transporters are differentially expressed among CNS cells.
F Zafra, C Aragón, L Olivares, N C Danbolt, C Giménez, J Storm-Mathisen. J Neurosci 1995
420
25

The transporters GlyT2 and VIAAT cooperate to determine the vesicular glycinergic phenotype.
Karin R Aubrey, Francesco M Rossi, Raquel Ruivo, Silvia Alboni, Gian Carlo Bellenchi, Anne Le Goff, Bruno Gasnier, Stéphane Supplisson. J Neurosci 2007
57
25

Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas.
Kenneth W Perry, Julie F Falcone, Matthew J Fell, John W Ryder, Hong Yu, Patrick L Love, Jason Katner, Kimberly D Gordon, Mark R Wade, Teresa Man,[...]. Neuropharmacology 2008
70
25

Glycine binding primes NMDA receptor internalization.
Yi Nong, Yue-Qiao Huang, William Ju, Lorraine V Kalia, Gholamreza Ahmadian, Yu Tian Wang, Michael W Salter. Nature 2003
314
25

Neuropathic pain: a maladaptive response of the nervous system to damage.
Michael Costigan, Joachim Scholz, Clifford J Woolf. Annu Rev Neurosci 2009
25

Functional 'glial' GLYT1 glycine transporters expressed in neurons.
Luca Raiteri, Maurizio Raiteri. J Neurochem 2010
35
25

Fast synaptic inhibition in spinal sensory processing and pain control.
Hanns Ulrich Zeilhofer, Hendrik Wildner, Gonzalo E Yévenes. Physiol Rev 2012
223
25

The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model.
Yasunori Haranishi, Koji Hara, Tadanori Terada, Seiya Nakamura, Takeyoshi Sata. Anesth Analg 2010
44
25

Models and mechanisms of hyperalgesia and allodynia.
Jürgen Sandkühler. Physiol Rev 2009
621
25


N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a.
Amy L Wiles, Rhonda-Jo Pearlman, Mari Rosvall, Karin R Aubrey, Robert J Vandenberg. J Neurochem 2006
66
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.